Stay updated on Immunotherapy with TIL in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.

Latest updates to the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; this appears to be a minor system update with no change to the study details presented.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedMaryland is now listed as a location under the Locations section, updating the trial's geographic availability. The Maryland Locations subsection and the HHS Vulnerability Disclosure link were removed as part of revision v3.3.3.SummaryDifference0.2%

- Check47 days agoChange DetectedSite revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe government funding lapse notice and operating status banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedOnly cosmetic/UI updates were observed. No changes to core study content, eligibility criteria, or outcomes were detected.SummaryDifference0.3%

Stay in the know with updates to Immunotherapy with TIL in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.